Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MyoSyntax

MyoSyntax
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$450K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of medical diagnostic products designed to improve physical performance and promote muscle health. The company's diagnostic product uses compelling technology to address the growing need for muscle health as well as uses one's blood and muscle sample to provide a personalized anabolic profile, enabling patients to optimize their muscle growth, maintain muscle mass and prevent muscle loss.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Primary Office
  • 60 Prescott Street
  • Worcester, MA 01605
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MyoSyntax’s full profile, request a free trial.

MyoSyntax Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2016 $450K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

MyoSyntax Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Massachusetts Biomedical Initiatives Accelerator/Incubator 000 0000 000000 0

MyoSyntax Executive Team (2)

Name Title Board
Seat
Contact
Info
Brian Mozeleski Ph.D Chief Executive Officer & Vice President
Monty Montano Ph.D Founder, President & Advisor